Editors’ Picks, March 2024: Synergy’s Impact on Resistance, New Early Detection Tools, and More
March's picks include how synergy drives drug resistance in AML, new early detection tools, and more.
March's picks include how synergy drives drug resistance in AML, new early detection tools, and more.
For the past five years, cohorts of talented young researchers from around the world have participated in the AACR...
For our readers who enjoy learning about the newest tools and strategies in cancer research, the second installment of...
As you prepare for trick-or-treating, check out the articles selected by the editors of the 10 AACR journals for...
In 2021, Lillian L. Siu, MD, and Elaine R. Mardis, PhD, FAACR, each received a call from AACR Chief...
Neuroblastoma, a rare cancer that occurs primarily in children, is a scientific paradox, said pediatric oncologist John M. Maris,...
The AACR Annual Meeting 2023, held April 14-19, commemorated several milestones, including the 25th anniversary of the approval of...
by Ashok Venkitaraman, MBBS, PhD Singapore will hold its 15th Frontiers in Cancer Science (FCS) conference November 6-8 at...
AACR is a pioneer in the study of racial/ethnic and other disparities in cancer research and care. The 16th...
Centuries ago, when several Native tribes in northeastern America were at constant war, a peacemaker came to stop the...
In the beginning of his cancer journey, Edward Cutler felt unlucky. In 2012, he saw an ad suggesting that...